About StemCell Institute
StemCell Institute is a company based in Tokyo (Japan) founded in 1999.. The company has 117 employees as of March 31, 2024. StemCell Institute operates in a competitive market with competitors including GenVault Corporation, iSpecimen, Indivumed, ViaCell and BioStorage Technologies, among others.
- Headquarter Tokyo, Japan
- Employees 117 as on 31 Mar, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Stemcell Institute
-
Annual Revenue
$17.93 M (USD)7.98as on Mar 31, 2025
-
Net Profit
$2.58 M (USD)24.06as on Mar 31, 2025
-
EBITDA
$3.66 M (USD)2.24as on Mar 31, 2025
-
Latest Funding Round
- Investors
-
Employee Count
117
as on Mar 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of StemCell Institute
StemCell Institute is a publicly listed company on the TSE with ticker symbol 7096 in Japan, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Funding Insights of StemCell Institute
- Total Funding Total Funding
- Total Rounds 1
- Last Round Last Round
- First Round First Round
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2008 | Amount | Private Equity Round - StemCell Institute | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in StemCell Institute
StemCell Institute has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Nagoya Small and Medium Business Investment & Consultation. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Long-term investment and consultation services are provided to SMEs.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by StemCell Institute
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - StemCell Institute
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Stemcell Institute Comparisons
Competitors of StemCell Institute
StemCell Institute operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GenVault Corporation, iSpecimen, Indivumed, ViaCell and BioStorage Technologies, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Biosamples are stabilized, transported, stored, and retrieved by GenVault.
|
|
| domain | founded_year | HQ Location |
Provider of a biorepository of human clinical specimens
|
|
| domain | founded_year | HQ Location |
Biospecimens are collected, preserved, and analyzed for oncology services.
|
|
| domain | founded_year | HQ Location |
Provider of services for collecting and preserving umbilical cord blood stem cells
|
|
| domain | founded_year | HQ Location |
Provides bio repository services
|
|
| domain | founded_year | HQ Location |
A blockchain-based platform for tokenizing and incentivizing stem cell donations
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Stemcell Institute
Frequently Asked Questions about StemCell Institute
When was StemCell Institute founded?
StemCell Institute was founded in 1999 and raised its 1st funding round 9 years after it was founded.
Where is StemCell Institute located?
StemCell Institute is headquartered in Tokyo, Japan. It is registered at Tokyo, Tokyo, Japan.
How many employees does StemCell Institute have?
As of Mar 31, 2024, the latest employee count at StemCell Institute is 117.
What is the annual revenue of StemCell Institute?
Annual revenue of StemCell Institute is $17.93M as on Mar 31, 2025.
What does StemCell Institute do?
The StemCell Institute was founded in 1999 in Tokyo, Japan, within the biotechnology sector. Private cord blood banking services are delivered through the Cell Cryopreservation Center and Cell Processing Center. Blood-derived cell products are processed and sold. Research and development efforts target stem cell-based treatments, along with medicines and medical devices. Cord blood units have been applied in treatments for leukemia and cerebral palsy.
Who are the top competitors of StemCell Institute?
StemCell Institute's top competitors include iSpecimen, AminoChain and GenVault Corporation.
Is StemCell Institute publicly traded?
Yes, StemCell Institute is publicly traded on TSE under the ticker symbol 7096.
Who are StemCell Institute's investors?
StemCell Institute has 1 investor. Key investors include Nagoya Small and Medium Business Investment & Consultation.
What is StemCell Institute's ticker symbol?
The ticker symbol of StemCell Institute is 7096 on TSE.